# Multi-scale disease modeling of SCN2A-related epilepsy due to gain-of-function variants

> **NIH NIH K08** · NORTHWESTERN UNIVERSITY · 2023 · $225,180

## Abstract

Project Summary Epilepsy affects up to 1% of the population worldwide, and 3 million in the United States
alone. A growing proportion of pediatric epilepsies are tied to causative variants in ion channel genes, including
the voltage-gated sodium channel gene SCN2A. The 2020 Epilepsy Research Benchmarks of NINDS prioritize
identifying how genetic variants cause epilepsy and related neurodevelopmental disorders. SCN2A variants that
manifest with loss-of-function are associated with severe neurodevelopmental disorders and late-onset epilepsy.
On the other hand, gain-of-function SCN2A variants predominantly have a phenotype of early-onset epilepsy.
The encoded sodium channel (NaV1.2) is highly expressed in excitatory glutamatergic neurons early in
development, presenting a unique opportunity to examine how excitatory neuron dysfunction leads to early-onset
epilepsy. Animal and human tissue-derived neuron models have brought mechanistic insight to how Dravet
syndrome results in interneuron dysfunction and epilepsy. Among SCN2A-related diseases, animal models
illuminate how loss-of-function leads to autism spectrum disorder with late-onset epilepsy. Due to lack of readily
available disease models, there is sparse mechanistic understanding of how excitatory neuron dysfunction early
in development leads to early-onset epilepsy. This proposal will exploit two early-onset epilepsy variants of
SCN2A that have a convergent clinical phenotype yet divergent biophysical mechanisms. Patient-derived neuron
models and mouse models provide the opportunity to define the point of mechanistic convergence at multiple
scales: from single neurons to neural circuits influencing epilepsy phenotype. Aim 1 will determine how two gain-
of-function SCN2A variants, encoding missense mutations M1879T and E430A, confer increased excitability by
distinct mechanisms. Functional analysis of iPSC-derived neurons in isolation and in elementary circuits will
define how the different variants impact excitability and thus converge toward an epileptic phenotype. Aim 2 will
define hippocampal higher-level circuit perturbations in epileptic mice designed with genome editing to
recapitulate the SCN2A-E430A human epileptic encephalopathy. Ex vivo analysis of changes in excitability,
synaptic signaling, and network output in the hippocampus will lead to new understanding of how gain-of-function
SCN2A variants affect neuronal networks. EEG and depth electrodes will provide spatiotemporal correlate to the
in vivo epilepsy phenotype. This proposal will propel the awardee to independence as a physician-scientist by
incorporating new expertise in multi-scale modeling of genetic epilepsy, focused relevant didactics, and a diverse
career development team specializing in neurodevelopmental and genetic disorders, all in a highly collaborative
environment fostering junior faculty development. This award will provide a platform to 1) define variant-specific
contributions to epilepsy phenotype in self-lim...

## Key facts

- **NIH application ID:** 10652642
- **Project number:** 5K08NS121601-02
- **Recipient organization:** NORTHWESTERN UNIVERSITY
- **Principal Investigator:** SCOTT K. ADNEY
- **Activity code:** K08 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $225,180
- **Award type:** 5
- **Project period:** 2022-07-01 → 2027-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10652642

## Citation

> US National Institutes of Health, RePORTER application 10652642, Multi-scale disease modeling of SCN2A-related epilepsy due to gain-of-function variants (5K08NS121601-02). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10652642. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*